We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01224067
Recruitment Status : Completed
First Posted : October 19, 2010
Last Update Posted : April 18, 2017
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Cambridge Health Alliance

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2008
  Study Completion Date : October 2008